Vulval squamous cell carcinoma is an under-reported cancer associated with poor outcomes: a national retrospective cohort study of the incidence and trends in England, 2013–2022
Vulval squamous cell carcinoma (VSCC) accounts for ∼90% of vulval cancers in England. Diagnosis is often delayed due to nonspecific presentations, limited screening, poor awareness and reluctance to undergo intimate examinations. Other than sentinel lymph node biopsies, management advances have been scarce. This national retrospective cohort study describes epidemiological trends, diagnostic stage, referral routes, treatment and survival in England (2013–2022) among self-identifying women.
Authors
- C. Harwood
- Jane Sterling (ORCID: https://orcid.org/0000-0003-0135-6458)
- Birgitta van Bodegraven (ORCID: https://orcid.org/0000-0002-8359-9017)
- Zoe Claire Venables (ORCID: https://orcid.org/0000-0002-9929-2693)
- Charlotte Sheern
- Andy Nordin
- Nick J. Levell
Institutions
- Queen Mary University of London (GB)
- Norwich University (US)
- Barts Health NHS Trust (GB)
- Norfolk and Norwich University Hospital (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- British Association of Dermatologists (GB)
- NHS Digital (GB)
- NHS England
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1093/bjd/ljag021
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00